Limited guidance and numerous challenges create confusion about the scope and timing of stability testing for drugs in development. The stability of clinical trial materials, regardless of the trial ...
Industry experts discuss the challenges and regulations of setting up a CGMP-compliant stability testing program. Pharmaceutical Technology Europe spoke with Bhroma Patel, head of product stability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback